A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Clinical trial NCT01069094 · COMPLETED

Trial details

NCT number: NCT01069094
Sponsor: Repros Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Uterine Leiomyomata

Start date: 2004-07-01
Primary completion: 2005-01-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.